Data

International Space Station (ISS)
#Data #Drug design #Drug discovery #GlobalData

Defying gravity: Space emerges as ‘laboratory for innovation’  

Space manufacturing could become a platform for scientific discovery and biomedical advancement, according to analytics company GlobalData.  Analysis from GlobalData suggests environments in space are increasingly accessible, with pharmaceutical and biotech companies focusing on low-Earth orbit to explore new opportunities. This includes advancing drug development,… Read More

#News

Genomics
#Data #Drug discovery #Genomics #Multi-omics

Advancing drug discovery through multiomics  

John Lepore, MD, CEO of ProFound Therapeutics, explore how multiomics, combined with artificial intelligence and real-world data is advancing drug discovery. The drug discovery landscape is undergoing a transformative shift, driven by the growing demand for precision medicine and tremendous technological advances that inform systems biology. Traditional R&D approaches… Read More

#Exclusive Content

Artificial intelligence
#AI #Data #Drug discovery #Merck

Merck and Siemens extend partnership for AI projects 

US pharmaceutical giant Merck and technology company Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership to accelerate AI and data-driven drug discovery and development.  The MoU focuses on delivering integrated software solutions, systems and consumables that harness automation, data and AI to… Read More

#Business & Investment #News

Rare diseases
#Data #Rare disease #Rare Disease Day

Rare disease research is changing, data says

This Rare Disease Day, Elsevier’s Scopus research and citation database analyses articles from millions of researchers, institutions and companies around the world to present data that suggests rare disease research has skyrocketed over the last ten years, but is starting to level off. According to the data, there was a… Read More

#News #Trends & Analysis

Future lab, AI and digital data
#Artificial intelligence (AI) #Data #Data automation #Lab of the future #Machine learning #Open Pharma Research #Pistoia Alliance

Lab of the Future survey reveals opinions on the use of AI  

The Pistoia Alliance has released the results of its annual Lab of the Future survey, conducted in partnership with Open Pharma Research. The survey of 200 experts spanning Europe, the Americas and APAC was presented at the Lab of the Future Congress in Amsterdam from 1-2 October 2024.   … Read More

#News

#Bioprinting #Cancer research #Cancer Research Horizons #Cancer Research UK #Cell therapy #Data #Data management #Data security #Drug development #Drug discovery #Electronic Lab Notebooks (ELN) #Laboratory data #Oncology #Organ manufacturing #Start-ups #Tissue engineering

Podcast looks behind the scenes of the drug discovery industry

This is the latest episode of the free DDW narrated podcast, titled “A look behind the scenes of the drug discovery industry” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Going paperless – the move to electronic lab… Read More

#News

Pathology data for HIV
#Biorepository #Data #HIV #National Institutes of Health (NIH) #Pathology #Proscia #The AIDS and Cancer Specimen Resource

Pathology data to advance discovery for HIV cancer patients 

The AIDS and Cancer Specimen Resource (ACSR), a biorepository of specimens collected from persons living with HIV (PLWH) established in 1994 and funded by the National Institutes of Health, National Cancer Institute, is using software from Proscia to encourage scientific exploration and discovery in cancer in PLWH.  … Read More

#News

#Data #Drug development #Drug discovery #Sustainability

Pistoia Alliance sets out strategic priorities in key areas of R&D  

The Pistoia Alliance has announced four new strategic priorities that will enable the not-for-profit group to accelerate key areas within R&D.  The Pistoia Alliance has appointed steering committees to lead collaboration in the areas of sustainability, adoption of AI, the use of real-world data and data-driven value. Read More

#News

#Data #Data security #Database #Thermo Fisher Scientific

New listicle: Three data problems solved by a connected lab

In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform.  How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team… Read More

#News

#Data #Data security #Database #Thermo Fisher Scientific

Listicle: Three data problems solved by a connected lab

In this listicle, Thermo Fisher Scientific outlines three problems solved by the Thermo Fisher Connect Platform Team Edition and below, they expand to five reasons why companies should consider this platform.  How do you secure your data? How do you share instruments? The Thermo Fisher Connect Platform Team… Read More

#Listicles #Videos

Innovation
#Advanced Therapies #Animal models #Autoimmune disease #Cell and gene therapy #Data #Genetics / genomics #Immunology #Pharma

New podcast on animal genomics, immunology and CGTs

This is the latest episode of the free DDW narrated podcast, “What’s at the forefront of innovation?” It covers three articles written for the for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Can animal genomics help find… Read More

#News

#Data #Drug development #Gene sequencing #Genome sequencing #Genomics #Healthcare #Precision medicine #Trusted research environment

Why Trusted Research Environments are key to the future of genomics  

Genomics is driving a revolution in drug development and, in the long run, the state of public healthcare. Advances in sequencing are leading to scientific breakthroughs in preventative care, faster diagnoses, and proactive medical interventions. Jack Dix, Head of Healthcare Strategy and Consulting at Kainos, expands.  Genetic… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Clinical trials #Covid-19 #Data #Disease surveillance #Global.health #Immunology / Virology & Vaccines

Fortifying vaccines through disease surveillance and data reporting  

Shelley McLendon, SVP of Vaccine and Infectious Diseases Program Management at ICON, attended the World Vaccine Congress Europe from 16-19 October 2022 in Barcelona, Spain. There, McLendon spoke on the topic of fortifying vaccines against future pandemics, specifically discussing: The importance of disease surveillance and reporting with regard to emerging… Read More

#Exclusive Content